Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Long-Term Care Facilities


Interviews

Canada’s top edible cannabis producer eyes further growth

Medicus Pharma advances cancer treatment towards phase II trial

Emerging opportunity in a growing, high-value dermatological market

Pharmaceutical company treats bladder cancer with new tech

Press Releases

PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

  Apr 22, 2024

FDA Advisory Panel Review of Guardant Health's Shield(TM) Blood Test to Screen for Colorectal...

  Apr 22, 2024

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM...

  Apr 22, 2024

Nova Leap Health Corp. to Discuss Record 2023 Results and Present at the Planet MicroCap...

  Apr 22, 2024

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...

  Apr 22, 2024

Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess...

  Apr 22, 2024

AGILITI INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC...

  Apr 22, 2024

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

  Apr 22, 2024

Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024

  Apr 22, 2024

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

  Apr 22, 2024

Profound Medical to Release First Quarter 2024 Financial Results on May 9 - Conference Call to...

  Apr 22, 2024

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy...

  Apr 22, 2024

ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in...

  Apr 22, 2024

Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction...

  Apr 22, 2024

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene...

  Apr 22, 2024

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated...

  Apr 22, 2024

Scorpius Holdings Announces Receipt of Filing Delinquency Notification

  Apr 22, 2024

ArriVent Appoints Kristine Peterson to its Board of Directors

  Apr 22, 2024

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

  Apr 22, 2024

Streamline Health® To Report Fourth Quarter and Fiscal Year 2023 Financial Performance

  Apr 22, 2024

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

  Apr 22, 2024

OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024

  Apr 22, 2024

Abeona Therapeutics Provides Regulatory Update on Pz-cel

  Apr 22, 2024

Xylo Technologies Files its 2023 Annual Report on Form 20-F

  Apr 22, 2024

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice

  Apr 22, 2024

Cidara Therapeutics Announces Reverse Stock Split

  Apr 22, 2024

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines...

  Apr 22, 2024

ProQR Highlights Upcoming Presentations on Axiomer(TM) RNA Editing at ASGCT 27th Annual Meeting

  Apr 22, 2024

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call...

  Apr 22, 2024

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023...

  Apr 22, 2024

Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

  Apr 22, 2024

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

  Apr 22, 2024

INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct...

  Apr 22, 2024

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

  Apr 22, 2024

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase...

  Apr 22, 2024

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the...

  Apr 22, 2024

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived...

  Apr 22, 2024

Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing...

  Apr 22, 2024

Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patient...

  Apr 22, 2024

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the...

  Apr 22, 2024

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its...

  Apr 22, 2024

Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of...

  Apr 22, 2024

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

  Apr 22, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc....

  Apr 22, 2024

Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 17, 2024 Deadline in Securities...

  Apr 22, 2024

Amarin Announces Results of Annual General Meeting of Shareholders

  Apr 22, 2024

Federman & Sherwood Announces Preliminary Approval of Settlement in Avem Health Partners, Inc....

  Apr 22, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity,...

  Apr 22, 2024

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with...

  Apr 22, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Apr 22, 2024

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE...

  Apr 23, 2024

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action...

  Apr 22, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities